Company Filing History:
Years Active: 1992-1993
Title: The Innovations of Tomokazu Ueki
Introduction
Tomokazu Ueki is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of novel enzymes and inhibitors. With a total of 3 patents to his name, Ueki's work has implications in cancer treatment and metabolic disorders.
Latest Patents
Ueki's latest patents include an arylsulfatase derived from microbial sources. This enzyme can be linked to an antibody targeting tumor-associated antigens, creating a conjugate that may be used alongside a sulfated prodrug of a 4'-demethylepipodophyllotoxin glucoside derivative, specifically etoposide, in cancer chemotherapy. Another significant patent is for a novel .alpha.-glucosidase inhibitor known as pradimicin Q, which has potential applications in treating metabolic disorders.
Career Highlights
Tomokazu Ueki is currently associated with Bristol-Myers Squibb Company, where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing therapeutic solutions that address critical health challenges.
Collaborations
Ueki collaborates with esteemed colleagues such as Yosuke Sawada and Toshikazu Oki. Their combined expertise enhances the research and development efforts within their projects.
Conclusion
Tomokazu Ueki's contributions to biochemistry and pharmaceutical innovations are noteworthy. His patents reflect a commitment to advancing medical science and improving patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.